Home    Back

Concerta    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
20322q11.2 deletion syndrome1

203. 22q11.2 deletion syndrome    [ 3 clinical trials,   3 drugs,   (DrugBank: 0),   0 drug target gene,   0 drug target pathway]
Searched query = "22q11.2 deletion syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 3 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04647500
(ClinicalTrials.gov)		August 26, 20163/11/2020Effects of Methylphenidate on Brain and Cognition in 22q11 Deletion SyndromeEffects of Modulation of the Dopaminergic System Using Methylphenidate on Memory and Executive Processes in Individuals With 22q11.2 Deletion Syndrome22q11.2 Deletion SyndromeDrug: ConcertaUniversity of Geneva, SwitzerlandNULLRecruiting8 Years25 YearsAll30N/ASwitzerland